Targeting APOBECs in cancer: It's about timing

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• APOBEC3 cytidine deaminases are implicated in mutagenesis across various cancer types.
• These enzymes play a significant role in tumor evolution and the development of drug resistance.

Purpose of the Study:

• To highlight the critical role of APOBEC3 enzymes in cancer mutagenesis.
• To emphasize the need for understanding APOBEC3-mediated mutagenesis for developing targeted cancer therapies.

Main Methods:

• This study is a review and synthesis of existing research on APOBEC3 enzymes.
• Focuses on the clinical implications of APOBEC3-driven mutagenesis.

Main Results:

• APOBEC3 enzymes are key drivers of mutations in numerous cancers.
• APOBEC3-mediated mutagenesis contributes to tumor evolution and acquired drug resistance.

Conclusions:

• Developing APOBEC3 inhibitors is a promising therapeutic strategy.
• Further research into the timing and consequences of APOBEC3 mutagenesis is crucial for effective anti-cancer drug development.